Internal Medicine · Fresno, CA
NPI
1679612436
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
1275 E Spruce Ave, Suite 101
Fresno, CA, 93720
Phone (559) 226-0848
Groups this clinician bills Medicare through
Medicare paid, 2024
$712K
41,018 services
Medicare patients, 2024
792
Average age 78
Drug cost, 2024
$1.8M
14,153 prescriptions
Company payments, 2025
$1,948
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael W Lynch was code J1071 (injection, testosterone cypionate, 1 mg), 24,250 times for 15 patients. In total Michael W Lynch billed 41,018 services in 71 codes, and Medicare paid $712K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 24,250 | 15 | $0.02 | $397 |
| 99213 Office E&M - Established | Office | 3,378 | 764 | $63.49 | $214K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 2,521 | 733 | $11.48 | $29K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,153 | 180 | $44.40 | $51K |
| 99214 Office E&M - Established | Office | 759 | 586 | $89.42 | $68K |
| 93000 Electrocardiogram | Office | 561 | 530 | $10.42 | $5,843 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 529 | 529 | $131.10 | $69K |
| 99232 Hospital E&M - Subsequent | Facility | 493 | 65 | $61.35 | $30K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 460 | 147 | $36.38 | $17K |
| G0008 Administration of influenza virus vaccine | Office | 379 | 372 | $32.66 | $12K |
| 90662 Vaccine Product | Office | 370 | 364 | $80.81 | $30K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 316 | 79 | $6.06 | $1,916 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 229 | 51 | $0.72 | $165 |
| 96372 Injection Administration | Office | 197 | 61 | $10.41 | $2,051 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 188 | 94 | $97.17 | $18K |
By year: 2022 $814K for 44,463 services; 2023 $808K for 43,845 services; 2024 $712K for 41,018 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael W Lynch prescribed most often to Medicare patients was Atorvastatin Calcium, with 768 prescriptions and refills. In total Michael W Lynch wrote 14,153 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 768 | 2,141 | 219 | $7,964 |
| Rosuvastatin Calcium Generic | 631 | 1,806 | 187 | $11K |
| Levothyroxine Sodium Generic | 585 | 1,663 | 149 | $6,664 |
| Lisinopril Generic | 436 | 1,158 | 120 | $3,313 |
| Amlodipine Besylate Generic | 408 | 1,078 | 121 | $2,808 |
| Metoprolol Succinate Generic | 370 | 972 | 103 | $5,488 |
| Eliquis Apixaban | 307 | 469 | 63 | $264K |
| Tamsulosin Hcl Generic | 302 | 802 | 82 | $5,007 |
| Famotidine Generic | 281 | 745 | 91 | $3,601 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 271 | 277 | 45 | $5,996 |
| Ezetimibe Generic | 259 | 630 | 95 | $6,285 |
| Gabapentin Generic | 255 | 438 | 55 | $3,342 |
| Valsartan Generic | 229 | 550 | 59 | $6,240 |
| Escitalopram Oxalate Generic | 199 | 400 | 47 | $2,816 |
| Carvedilol Generic | 198 | 529 | 55 | $1,834 |
Brand drugs: 1,907 claims; generic drugs: 12,200 claims; opioid claims: 536.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael W Lynch $1,948 ($1,948 in general payments such as food, travel and fees) from 22 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $320.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $320 |
| Lilly USA, LLC LLY | 7 | $316 |
| Radius Health, Inc. | 6 | $200 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $170 |
| Pfizer Inc. PFE | 9 | $163 |
| Eisai Inc. 4523.T | 1 | $125 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $115 |
| Abbvie Inc. ABBV | 5 | $103 |
| Abbott Laboratories ABT | 3 | $63.39 |
| Abiomed JNJ | 3 | $58.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.